Precision Oncology: DPYD and UGT1A1 Testing for Safer Chemotherapy in Real-World Practice

Speakers Dr. Erika Cecchin, PharmD, PhD Clinical Pharmacologist –Experimental and Clinical Pharmacology (ECP) Aviano National Cancer Institute (CRO), IRCCS (italy) “Personalizing Cancer Therapy Through Pharmacogenetics: DPYD, UGT1A1 and beyond” Dr. Stefania Tommasi Head – Unit of Molecular Diagnostics and Pharmacogenetics Giovanni Paolo II Cancer Institute, Bari (Italy) “Implementing DPYD and UGT1A1 Testing in Clinical Practice” […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving the U.S. & Canada Research Use Only (RUO) area.

The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.

logo Diatech Pharmacogenetics
Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.